{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:32:53Z","timestamp":1783128773959,"version":"3.54.6"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The spread of biofilm-forming multidrug-resistant pathogenic bacteria is an alarming public health issue requiring significant research. Drug repurposing is a novel approach to combating bacterial infections that is currently being studied. Here, we explored diclofenac sodium\u2019s potential antibacterial and antibiofilm action on <jats:italic>Staphylococcus epidermidis<\/jats:italic> bacteria. Diclofenac sodium revealed antibacterial action on <jats:italic>S. epidermidis<\/jats:italic> isolates with minimum inhibitory concentrations of 500 to 2000\u00a0\u00b5g\/mL. It also exposed antibiofilm action using the crystal violet assay and scanning electron microscope. Using qRT-PCR, diclofenac sodium has downregulated the expression of the biofilm genes (<jats:italic>cna<\/jats:italic>, <jats:italic>fnb<\/jats:italic>A, and <jats:italic>ica<\/jats:italic>) in 20% of the isolates. An animal model revealed the effect of diclofenac sodium on a systemic infection with <jats:italic>S. epidermidis<\/jats:italic> in mice. Diclofenac sodium has improved the liver, spleen, and kidney architecture. Molecular docking was used to explore the possible mechanism for the activity of diclofenac sodium against <jats:italic>S. epidermidis<\/jats:italic>, which revealed the high affinity of diclofenac sodium toward <jats:italic>S. epidermidis<\/jats:italic> protein and TcaR enzymes. Thus, diclofenac sodium could be a clinical solution for disseminating resistance among <jats:italic>S. epidermidis<\/jats:italic> and could be investigated for its combination with different antibiotics in future studies.<\/jats:p>","DOI":"10.1038\/s41598-025-14316-1","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T09:28:04Z","timestamp":1756200484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Employing diclofenac sodium as a novel therapeutic frontier for Staphylococcus epidermidis infections"],"prefix":"10.1038","volume":"15","author":[{"given":"Amal M.","family":"Abo-Kamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa E.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz A.","family":"Shaldam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engy","family":"Elekhnawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"14316_CR1","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/jac\/dkq257","volume":"65","author":"R Singh","year":"2010","unstructured":"Singh, R., Ray, P., Das, A. & Sharma, M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Antimicrob. Chemother. 65, 1955\u20131958 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"14316_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jac\/44.1.43","volume":"44","author":"B Amorena","year":"1999","unstructured":"Amorena, B. et al. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J. Antimicrob. Chemother. 44, 43\u201355 (1999).","journal-title":"J. Antimicrob. Chemother."},{"key":"14316_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1128\/IAI.70.2.631-641.2002","volume":"70","author":"S Jarraud","year":"2002","unstructured":"Jarraud, S. et al. Relationships between Staphylococcus aureus genetic background, virulence factors, Agr groups (alleles), and human disease. Infect. Immun. 70, 631\u2013641 (2002).","journal-title":"Infect. Immun."},{"key":"14316_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1128\/jcm.1.3.256-261.1975","volume":"1","author":"BM Males","year":"1975","unstructured":"Males, B. M., Rogers, W. A. Jr & Parisi, J. T. Virulence factors of biotypes of Staphylococcus epidermidis from clinical sources. J. Clin. Microbiol. 1, 256\u2013261 (1975).","journal-title":"J. Clin. Microbiol."},{"key":"14316_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/cjm-2024-0155","volume":"71","author":"S Datta","year":"2024","unstructured":"Datta, S., Singh, V., Nag, S. & Roy, D. N. Carvacrol, a monoterpenoid, binds quorum sensing proteins (LasI and LasR) and swarming motility protein BswR of Pseudomonas aeruginosa, resulting in loss of pathogenicity: an in Silico approach. Can. J. Microbiol. 71, 1\u201315 (2024).","journal-title":"Can. J. Microbiol."},{"key":"14316_CR6","doi-asserted-by":"publisher","first-page":"119144","DOI":"10.1016\/j.jep.2024.119144","volume":"339","author":"N Moktan","year":"2025","unstructured":"Moktan, N. et al. Antibacterial and antibiofilm activities of extract and bioactive compounds from Bergenia ciliata (Haw.) sternb. Flowers against Streptococcus mutans through cell membrane damage. J. Ethnopharmacol. 339, 119144 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"14316_CR7","unstructured":"Roy, D. N. A complete guidebook on biofilm study; Academic Press: (2022)."},{"key":"14316_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.tim.2004.11.006","volume":"13","author":"SS Branda","year":"2005","unstructured":"Branda, S. S., Vik, \u00c5., Friedman, L. & Kolter, R. Biofilms: the matrix revisited. Trends Microbiol. 13, 20\u201326 (2005).","journal-title":"Trends Microbiol."},{"key":"14316_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/antibiotics11080993","volume":"11","author":"NG Attallah","year":"2022","unstructured":"Attallah, N. G. et al. Anti-Biofilm and antibacterial activities of Cycas media R. Br secondary metabolites: in silico, in vitro, and in vivo approaches. Antibiotics 11, 993 (2022).","journal-title":"Antibiotics"},{"key":"14316_CR10","doi-asserted-by":"crossref","unstructured":"Datta, S., Singh, V., Nag, S. & Roy, D. N. Marine-Derived cytosine arabinoside (Ara-C) inhibits biofilm formation by inhibiting PEL Operon proteins (Pel A and Pel B) of Pseudomonas aeruginosa: an in Silico approach. Molecular Biotechnology 671\u201315. (2024).","DOI":"10.1007\/s12033-024-01169-8"},{"key":"14316_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0924-8579(00)00299-5","volume":"16","author":"DM Livermore","year":"2000","unstructured":"Livermore, D. M. Antibiotic resistance in Staphylococci. Int. J. Antimicrob. Agents. 16, 3\u201310 (2000).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"14316_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","volume":"9","author":"TFC Mah","year":"2001","unstructured":"Mah, T. F. C. & O\u2019Toole, G. A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9, 34\u201339 (2001).","journal-title":"Trends Microbiol."},{"key":"14316_CR13","doi-asserted-by":"publisher","first-page":"113402","DOI":"10.1016\/j.ejmech.2021.113402","volume":"219","author":"RK Hansa","year":"2021","unstructured":"Hansa, R. K. et al. 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl) phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents. Eur. J. Med. Chem. 219, 113402 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"14316_CR14","doi-asserted-by":"publisher","first-page":"7931","DOI":"10.1038\/s41598-021-86852-5","volume":"11","author":"R Provenzani","year":"2021","unstructured":"Provenzani, R. et al. Multisubstituted pyrimidines effectively inhibit bacterial growth and biofilm formation of Staphylococcus aureus. Sci. Rep. 11, 7931 (2021).","journal-title":"Sci. Rep."},{"key":"14316_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00203-023-03639-0","volume":"205","author":"OM Al-Fakhrany","year":"2023","unstructured":"Al-Fakhrany, O. M. & Elekhnawy, E. Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents. Arch. Microbiol. 205, 301 (2023).","journal-title":"Arch. Microbiol."},{"key":"14316_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discovery. 6, 29\u201340 (2007).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"14316_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/antibiotics8020045","volume":"8","author":"B Ribeiro da Cunha","year":"2019","unstructured":"Ribeiro da Cunha, B., Fonseca, L. P. & Calado, C. R. Antibiotic discovery: where have we come from, where do we go? Antibiotics 8, 45 (2019).","journal-title":"Antibiotics"},{"key":"14316_CR18","doi-asserted-by":"publisher","first-page":"833005","DOI":"10.3389\/fphar.2022.833005","volume":"13","author":"A Talat","year":"2022","unstructured":"Talat, A., Bashir, Y. & Khan, A. U. Repurposing of antibiotics: sense or non-sense. Front. Pharmacol. 13, 833005 (2022).","journal-title":"Front. Pharmacol."},{"key":"14316_CR19","doi-asserted-by":"publisher","first-page":"684515","DOI":"10.3389\/fcimb.2021.684515","volume":"11","author":"NK Boyd","year":"2021","unstructured":"Boyd, N. K., Teng, C. & Frei, C. R. Brief overview of approaches and challenges in new antibiotic development: a focus on drug repurposing. Front. Cell. Infect. Microbiol. 11, 684515 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"14316_CR20","unstructured":"Forbes, B. A., Sahm, D. F. & Weissfeld, A. S. Diagnostic microbiology; Mosby St Louis: (2007)."},{"key":"14316_CR21","first-page":"265","volume":"7","author":"MS Al-Zoubi","year":"2015","unstructured":"Al-Zoubi, M. S., Al-Tayyar, I. A., Hussein, E., Al Jabali, A. & Khudairat, S. Antimicrobial susceptibility pattern of Staphylococcus aureus isolated from clinical specimens in Northern area of Jordan. Iran. J. Microbiol. 7, 265 (2015).","journal-title":"Iran. J. Microbiol."},{"key":"14316_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-022-02751-3","volume":"23","author":"C Guan","year":"2023","unstructured":"Guan, C. et al. Antibacterial and antibiofilm potential of Lacticaseibacillus rhamnosus YT and its cell-surface extract. BMC Microbiol. 23, 1\u201310 (2023).","journal-title":"BMC Microbiol."},{"key":"14316_CR23","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1080\/10717544.2022.2083725","volume":"29","author":"B Alotaibi","year":"2022","unstructured":"Alotaibi, B. et al. Aqueous core Epigallocatechin gallate PLGA nanocapsules: characterization, antibacterial activity against uropathogens, and in vivo reno-protective effect in cisplatin induced nephrotoxicity. Drug Deliv. 29, 1848\u20131862 (2022).","journal-title":"Drug Deliv."},{"key":"14316_CR24","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/jof8050426","volume":"8","author":"WA Negm","year":"2022","unstructured":"Negm, W. A. et al. Promising antifungal activity of encephalartos Laurentianus de wild against Candida albicans clinical isolates: in vitro and in vivo effects on renal cortex of adult albino rats. J. Fungi. 8, 426 (2022).","journal-title":"J. Fungi"},{"key":"14316_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/jof8050521","volume":"8","author":"MJ Alqahtani","year":"2022","unstructured":"Alqahtani, M. J., Elekhnawy, E., Negm, W. A., Mahgoub, S. & Hussein, I. A. Encephalartos villosus lem. Displays a strong in vivo and in vitro antifungal potential against Candida glabrata clinical isolates. J. Fungi. 8, 521 (2022).","journal-title":"J. Fungi"},{"key":"14316_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-020-05413-7","volume":"14","author":"V David","year":"2021","unstructured":"David, V. et al. Validation of a method of broth microdilution for the determination of antibacterial activity of essential oils. BMC Res. Notes. 14, 1\u20137 (2021).","journal-title":"BMC Res. Notes"},{"key":"14316_CR27","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/ph15091043","volume":"15","author":"R Binsuwaidan","year":"2022","unstructured":"Binsuwaidan, R. et al. Bilosomes as nanoplatform for oral delivery and modulated in vivo antimicrobial activity of lycopene. Pharmaceuticals 15, 1043 (2022).","journal-title":"Pharmaceuticals"},{"key":"14316_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-021-00170-z","volume":"22","author":"EA Elekhnawy","year":"2021","unstructured":"Elekhnawy, E. A., Sonbol, F. I., Elbanna, T. E. & Abdelaziz, A. A. Evaluation of the impact of adaptation of Klebsiella pneumoniae clinical isolates to Benzalkonium chloride on biofilm formation. Egypt. J. Med. Hum. Genet. 22, 1\u20136 (2021).","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"14316_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"S Stepanovi\u0107","year":"2007","unstructured":"Stepanovi\u0107, S. et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci. Apmis 115, 891\u2013899 (2007).","journal-title":"Apmis"},{"key":"14316_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/jof8101005","volume":"8","author":"FA Alherz","year":"2022","unstructured":"Alherz, F. A. et al. Silver nanoparticles prepared using encephalartos Laurentianus de wild leaf extract have inhibitory activity against Candida albicans clinical isolates. J. Fungi. 8, 1005 (2022).","journal-title":"J. Fungi"},{"key":"14316_CR31","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.3390\/molecules27227841","volume":"27","author":"FM Abdel Bar","year":"2022","unstructured":"Abdel Bar, F. M. et al. Anti-quorum sensing and anti-biofilm activity of pelargonium\u00d7 hortorum root extract against Pseudomonas aeruginosa: combinatorial effect of Catechin and Gallic acid. Molecules 27, 7841 (2022).","journal-title":"Molecules"},{"key":"14316_CR32","doi-asserted-by":"publisher","first-page":"e0213079","DOI":"10.1371\/journal.pone.0213079","volume":"14","author":"TH Ong","year":"2019","unstructured":"Ong, T. H. et al. Cationic chitosan-propolis nanoparticles alter the zeta potential of S. epidermidis, inhibit biofilm formation by modulating gene expression and exhibit synergism with antibiotics. PloS One. 14, e0213079 (2019).","journal-title":"PloS One"},{"key":"14316_CR33","unstructured":"Nourbakhsh, F. & Namvar, A. E. Detection of genes involved in biofilm formation in Staphylococcus aureus isolates. GMS Hygiene and infection control 11. (2016)."},{"key":"14316_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.meegid.2013.05.002","volume":"18","author":"SS Atshan","year":"2013","unstructured":"Atshan, S. S. et al. Quantitative PCR analysis of genes expressed during biofilm development of methicillin resistant Staphylococcus aureus (MRSA). Infect. Genet. Evol. 18, 106\u2013112 (2013).","journal-title":"Infect. Genet. Evol."},{"key":"14316_CR35","doi-asserted-by":"crossref","unstructured":"Atshan, S. S. et al. Quantitative PCR analysis of genes expressed during biofilm development of methicillin resistant Staphylococcus aureus (MRSA). infection, genetics, and evolution 18, 106\u2013112. (2013).","DOI":"10.1016\/j.meegid.2013.05.002"},{"key":"14316_CR36","first-page":"Doc07","volume":"11","author":"F Nourbakhsh","year":"2016","unstructured":"Nourbakhsh, F. & Namvar, A. E. Detection of genes involved in biofilm formation in Staphylococcus aureus isolates. GMS Hygiene Infect. Control. 11, Doc07 (2016).","journal-title":"GMS Hygiene Infect. Control"},{"key":"14316_CR37","doi-asserted-by":"publisher","first-page":"e22161","DOI":"10.1371\/journal.pone.0022161","volume":"6","author":"J Zheng","year":"2011","unstructured":"Zheng, J. et al. Differential gene expression by RamA in ciprofloxacin-resistant Salmonella typhimurium. PLoS One. 6, e22161 (2011).","journal-title":"PLoS One"},{"key":"14316_CR38","doi-asserted-by":"publisher","first-page":"2100681","DOI":"10.1002\/advs.202100681","volume":"8","author":"S Zhang","year":"2021","unstructured":"Zhang, S. et al. Diclofenac resensitizes Methicillin-Resistant Staphylococcus aureus to \u03b2\u2010Lactams and prevents implant infections. Adv. Sci. 8, 2100681 (2021).","journal-title":"Adv. Sci."},{"key":"14316_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2106\/JBJS.16.01002","volume":"99","author":"JM Thompson","year":"2017","unstructured":"Thompson, J. M. et al. Oral-only linezolid-rifampin is highly effective compared with other antibiotics for periprosthetic joint infection: study of a mouse model. J. Bone Joint Surg. Am. Vol. 99, 656 (2017).","journal-title":"J. Bone Joint Surg. Am. Vol."},{"key":"14316_CR40","first-page":"1361","volume":"15","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy, H. M. et al. Potential therapeutic benefits of Metformin alone and in combination with sitagliptin in the management of type 2 diabetes patients with COVID-19. Pharm 15, 1361 (2022).","journal-title":"Pharm"},{"key":"14316_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334 (2010).","journal-title":"J. Comput. Chem."},{"key":"14316_CR42","doi-asserted-by":"crossref","unstructured":"Stackhouse, R. R., Faith, N. G., Kaspar, C. W., Czuprynski, C. J. & Wong, A. C. L. J. A. microbiology, e. Survival and virulence of Salmonella enterica serovar enteritidis filaments induced by reduced water activity. Applied and environmental microbiology78, 2213\u20132220 (2012).","DOI":"10.1128\/AEM.06774-11"},{"key":"14316_CR43","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s10787-022-01078-9","volume":"30","author":"BM Alomair","year":"2022","unstructured":"Alomair, B. M. et al. Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy? Inflammopharmacology 30, 2411\u20132415 (2022).","journal-title":"Inflammopharmacology"},{"key":"14316_CR44","doi-asserted-by":"publisher","first-page":"8617","DOI":"10.1073\/pnas.0913302107","volume":"107","author":"YM Chang","year":"2010","unstructured":"Chang, Y. M. et al. Structural study of TcaR and its complexes with multiple antibiotics from Staphylococcus epidermidis. Proc. Natl. Acad. Sci. U.S.A. 107, 8617\u20138622. https:\/\/doi.org\/10.1073\/pnas.0913302107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"14316_CR45","doi-asserted-by":"publisher","first-page":"866343","DOI":"10.3389\/fmed.2022.866343","volume":"9","author":"D Hasan Khudhair","year":"2022","unstructured":"Hasan Khudhair, D. et al. Combination of vitamin C and Curcumin safeguards against methotrexate-induced acute liver injury in mice by synergistic antioxidant effects. Front. Med. 9, 866343 (2022).","journal-title":"Front. Med."},{"key":"14316_CR46","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola, C. L. The antibiotic resistance crisis: part 1: causes and threats. Pharm. Ther. 40, 277 (2015).","journal-title":"Pharm. Ther."},{"key":"14316_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrmicro1818","volume":"6","author":"L Cegelski","year":"2008","unstructured":"Cegelski, L., Marshall, G. R., Eldridge, G. R. & Hultgren, S. J. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 6, 17\u201327 (2008).","journal-title":"Nat. Rev. Microbiol."},{"key":"14316_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.tim.2017.10.005","volume":"26","author":"T Defoirdt","year":"2018","unstructured":"Defoirdt, T. Quorum-sensing systems as targets for antivirulence therapy. Trends Microbiol. 26, 313\u2013328 (2018).","journal-title":"Trends Microbiol."},{"key":"14316_CR49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci, F., Pezzotti, P. & Pantosti, A. Antimicrobial resistance: a global multifaceted phenomenon. Pathogens Global Health. 109, 309\u2013318 (2015).","journal-title":"Pathogens Global Health"},{"key":"14316_CR50","doi-asserted-by":"publisher","first-page":"e14030","DOI":"10.7717\/peerj.14030","volume":"10","author":"VI Mart\u00ednez-Santos","year":"2022","unstructured":"Mart\u00ednez-Santos, V. I., Torres-A\u00f1orve, D. A., Ech\u00e1niz-Aviles, G., Parra-Rojas, I. & Ram\u00edrez-Peralta, A. Castro-Alarc\u00f3n, N. Characterization of Staphylococcus epidermidis clinical isolates from hospitalized patients with bloodstream infection obtained in two time periods. PeerJ 10, e14030 (2022).","journal-title":"PeerJ"},{"key":"14316_CR51","doi-asserted-by":"publisher","first-page":"001","DOI":"10.7324\/JAPS.2022.120601","volume":"12","author":"A Ahmadunissah","year":"2022","unstructured":"Ahmadunissah, A., Aazmi, S., Abd Hamid, U. M. & Abdul-Aziz, A. Multidrug resistance of Staphylococcus epidermidis: an emerging threat to global health. J. Appl. Pharm. Sci. 12, 001\u2013010 (2022).","journal-title":"J. Appl. Pharm. Sci."},{"key":"14316_CR52","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/life13051126","volume":"13","author":"V Siciliano","year":"2023","unstructured":"Siciliano, V., Passerotto, R. A., Chiuchiarelli, M., Leanza, G. M. & Ojetti, V. Difficult-to-Treat pathogens: A review on the management of Multidrug-Resistant Staphylococcus epidermidis. Life 13, 1126 (2023).","journal-title":"Life"},{"key":"14316_CR53","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fmicb.2015.00282","volume":"6","author":"A Rangel-Vega","year":"2015","unstructured":"Rangel-Vega, A., Bernstein, L. R., Mandujano-Tinoco, E. A., Garc\u00eda-Contreras, S. J. & Garc\u00eda-Contreras, R. Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections. Front. Microbiol. 6, 282 (2015).","journal-title":"Front. Microbiol."},{"key":"14316_CR54","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2174\/1381612821666150310104416","volume":"21","author":"S Thangamani","year":"2015","unstructured":"Thangamani, S., Mohammad, H., Younis, W. & Seleem, N. Drug repurposing for the treatment of Staphylococcal infections. Curr. Pharm. Design. 21, 2089\u20132100 (2015).","journal-title":"Curr. Pharm. Design"},{"key":"14316_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/antibiotics9030107","volume":"9","author":"M Lagadinou","year":"2020","unstructured":"Lagadinou, M. et al. Antimicrobial properties on non-antibiotic drugs in the era of increased bacterial resistance. Antibiotics 9, 107 (2020).","journal-title":"Antibiotics"},{"key":"14316_CR56","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/antibiotics9090591","volume":"9","author":"C Le\u00e3o","year":"2020","unstructured":"Le\u00e3o, C., Borges, A. & Sim\u00f5es, M. NSAIDs as a drug repurposing strategy for biofilm control. Antibiotics 9, 591 (2020).","journal-title":"Antibiotics"},{"key":"14316_CR57","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/antibiotics11060816","volume":"11","author":"A Barbarossa","year":"2022","unstructured":"Barbarossa, A. et al. Non-antibiotic drug repositioning as an alternative antimicrobial approach. Antibiotics 11, 816 (2022).","journal-title":"Antibiotics"},{"key":"14316_CR58","first-page":"16","volume":"10","author":"A Salem-Milani","year":"2013","unstructured":"Salem-Milani, A. et al. Antibacterial effect of diclofenac sodium on Enterococcus faecalis. J. Dentistry (Tehran Iran). 10, 16 (2013).","journal-title":"J. Dentistry (Tehran Iran)"},{"key":"14316_CR59","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/femsre\/fux007","volume":"41","author":"TJ Foster","year":"2017","unstructured":"Foster, T. J. Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol. Rev. 41, 430\u2013449 (2017).","journal-title":"FEMS Microbiol. Rev."},{"key":"14316_CR60","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.1021\/acsomega.7b01368","volume":"2","author":"A Petchiappan","year":"2017","unstructured":"Petchiappan, A. & Chatterji, D. Antibiotic resistance: current perspectives. ACS Omega. 2, 7400\u20137409 (2017).","journal-title":"ACS Omega"},{"key":"14316_CR61","doi-asserted-by":"crossref","unstructured":"Otto, M. Staphylococcal biofilms. Bacterial biofilms\u00a0, 207\u2013228\u00a02008.","DOI":"10.1007\/978-3-540-75418-3_10"},{"key":"14316_CR62","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/antibiotics12030450","volume":"12","author":"CM Ferrer-Luque","year":"2023","unstructured":"Ferrer-Luque, C. M., Solana, C., Aguado, B. & Ruiz-Linares, M. Antimicrobial activity and cytotoxicity of nonsteroidal Anti-Inflammatory drugs against endodontic biofilms. Antibiotics 12, 450 (2023).","journal-title":"Antibiotics"},{"key":"14316_CR63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.femsle.2005.03.035","volume":"246","author":"CR Arciola","year":"2005","unstructured":"Arciola, C. R., Campoccia, D., Gamberini, S., Baldassarri, L. & Montanaro, L. Prevalence of Cna FnbA and FnbB adhesin genes among Staphylococcus aureus isolates from orthopedic infections associated to different types of implant. FEMS Microbiol. Lett. 246, 81\u201386 (2005).","journal-title":"FEMS Microbiol. Lett."},{"key":"14316_CR64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejmhg.2012.04.007","volume":"13","author":"RA Nasr","year":"2012","unstructured":"Nasr, R. A., AbuShady, H. M. & Hussein, H. S. Biofilm formation and presence of IcaAD gene in clinical isolates of Staphylococci. Egypt. J. Med. Hum. Genet. 13, 269\u2013274 (2012).","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"14316_CR65","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2191-219X-3-8","volume":"3","author":"A Signore","year":"2013","unstructured":"Signore, A. About inflammation and infection. EJNMMI Res. 3, 8 (2013).","journal-title":"EJNMMI Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14316-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14316-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14316-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:18:42Z","timestamp":1757485122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14316-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14316"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14316-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were carried out by relevant guidelines and regulations. The experimental procedures were approved by the ethics committee at the faculty of pharmacy, Tanta University (TP\/RE\/3\/24 p-01) following ARRIVE guidelines. No consent to participate was used as there is no patients in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable. No patients were involved in the study as the bacteria was isolated from the specimens that were obtained from patients for routine diagnosis in the hospital and not specifically for this study. The patient data were completely obscured so no consent was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}}],"article-number":"31377"}}